New drugs for severe asthma – what should we target and how?

K.F. Chung (London, United Kingdom)

Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Number: 6
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K.F. Chung (London, United Kingdom). New drugs for severe asthma – what should we target and how?. Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


How common is stepping-down asthma treatment in England?
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019

New treatments in severe paediatric asthma
Source: International Congress 2017 – PG7 Paediatric asthma
Year: 2017


Treatment of severe childhood asthma: what’s the evidence?
Source: Annual Congress 2005 - Difficult asthma in children
Year: 2005

Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


Do we need new therapies for noneosinophilic asthma?
Source: Annual Congress 2004 - Noneosinophilic asthma
Year: 2004

New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Year: 2021



Managing severe asthma: do we need to do more?
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007

New mechanisms and targets in COPD
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014



New guidelines for chronic cough: what’s in and what’s out
Source: International Congress 2019 – New clinical practice guidelines for chronic cough
Year: 2019


Update on severe asthma: what we know and what we need
Source: Eur Respir Rev 2009; 18: 58-65
Year: 2009


Only severe asthma?
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019


Potential drugs to treat smokers with asthma
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007



New perspectives of basic aspirin-induced asthma therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003